$25.3M Raised for Leo Cancer Care to Continue Their Mission to be ‘The More Human Way to Deliver Radiation Therapy’
Summary
LONDON, UK / ACCESSWIRE / July 20, 2021 / Leo Cancer Care is an innovative start-up company that is set to change the face of Radiation Therapy forever. The fundraise has seen investments from investors located all across the globe, some of the largest investors in the fundraise alongside Pureland were investment companies Yu Galaxy, WARF, Alumni Ventures, Junson Capital and Serra Ventures as well as industry leaders CHC, Cosylab, Toret Devices and Radiation Business Solutions.This successful collaboration has led to $25.3M being raised to support Leo Cancer Care to continue the development of their state-of-the-art upright radiotherapy solutions, which offer significant improvements to clinical effectiveness and patient experience. Leo Cancer Cares gantry-less solutions utilize a fixed beam meaning they have a much smaller footprint compared to existing radiotherapy machines, making them much more affordable and easier to install and maintain. By removing the need for a gantry and introducing slow patient rotation, Leo Cancer Care has the opportunity to take Photon Therapy on the road and have plans to create a mobile solution that will take this form of treatment to more people, in more places. Their family of world-class radiation therapy solutions can provide a streamlined and efficient treatment, whilst making the patient feel in control and hopeful.